{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:22:50Z","timestamp":1790504570968,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.canep.2012.07.012","type":"journal-article","created":{"date-parts":[[2012,8,19]],"date-time":"2012-08-19T16:47:07Z","timestamp":1345394827000},"page":"e349-e353","source":"Crossref","is-referenced-by-count":38,"title":["Epidemiology of castration resistant prostate cancer: A longitudinal analysis using a UK primary care database"],"prefix":"10.1016","volume":"36","author":[{"given":"C.J.","family":"Hirst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.canep.2012.07.012_bib0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canep.2012.07.012_bib0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.pcan.4500880","article-title":"The changing pattern of management for hormone-refractory, metastatic prostate cancer","volume":"9","author":"James","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.canep.2012.07.012_bib0015","series-title":"International conference for pharmacoepidemiology","article-title":"Comorbidity among hormone resistant prostate cancer patients in the US","author":"Cabrera","year":"2010"},{"issue":"3 (Pt 1)","key":"10.1016\/j.canep.2012.07.012_bib0020","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.juro.2007.05.018","article-title":"Chromogranin A expression in patients with hormone na\u00efve prostate cancer predicts the development of hormone refractory disease","volume":"178","author":"Berruti","year":"2007","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.canep.2012.07.012_bib0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3816\/CGC.2003.n.006","article-title":"Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate cancer","volume":"1","author":"Bianco","year":"2003","journal-title":"Clin Prostate Cancer"},{"issue":"11","key":"10.1016\/j.canep.2012.07.012_bib0030","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1742-1241.2011.02799.x","article-title":"Characterising the castration-resistant prostate cancer population: a systematic review","volume":"65","author":"Kirby","year":"2011","journal-title":"Int J Clin Pract"},{"issue":"2","key":"10.1016\/j.canep.2012.07.012_bib0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10552-007-9083-8","article-title":"Quantifying the role of PSA screening in the US prostate cancer mortality decline","volume":"19","author":"Etzioni","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canep.2012.07.012_bib0040","series-title":"International society for pharmacoeconomics and outcomes research 2010; 15th annual meeting","article-title":"Castrate resistant prostate cancer (CRPC): a UK epidemiology study","author":"Morgan","year":"2010"},{"issue":"2","key":"10.1016\/j.canep.2012.07.012_bib0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3111\/13696998.2010.491435","article-title":"Economic burden and healthcare utilization associated with castrate resistant prostate cancer in a commercial and medicare advantage US patient population","volume":"13","author":"Alemayehu","year":"2010","journal-title":"J Med Econ"},{"key":"10.1016\/j.canep.2012.07.012_bib0050","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/bmj.302.6779.766","article-title":"Validation of information recorded on general practitioner based computerized data resources in the United Kingdom","volume":"302","author":"Jick","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.canep.2012.07.012_bib0055","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1592\/phco.23.5.686.32205","article-title":"Validity of the general practice research database","volume":"23","author":"Jick","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.canep.2012.07.012_bib0060","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1055-9965.649.13.4","article-title":"Inverse association between nonsteriodal anti-inflammatory drugs and prostate cancer","volume":"13","author":"Garcia Rodriguez","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.canep.2012.07.012_bib0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/pros.10294","article-title":"Association between captopril, other antihypertensive drugs and risk of prostate cancer","volume":"58","author":"Ronquist","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.canep.2012.07.012_bib0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"6","key":"10.1016\/j.canep.2012.07.012_bib0075","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.bjc.6602767","article-title":"Predictive factors for skeletal complications in hormone refractory prostate cancer patients with metastatic bone disease","volume":"93","author":"Berruti","year":"2005","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.canep.2012.07.012_bib0080","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.urology.2008.07.062","article-title":"Prevalence of skeletal complications and their impact on survival of hormone refractory prostate cancer patients in Japan","volume":"73","author":"Inoue","year":"2009","journal-title":"Urology"},{"issue":"13","key":"10.1016\/j.canep.2012.07.012_bib0085","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1200\/JCO.2005.01.529","article-title":"Natural history of rising serum prostate specific antigen in men with castrate nonmetastatic prostate cancer","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canep.2012.07.012_bib0090","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCULATIONAHA.109.192695","article-title":"Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association American Cancer Society, and American Urological Association","volume":"121","author":"Levine","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.canep.2012.07.012_bib0095","unstructured":"Melia J. Second survey of prostate specific antigen services in England. National Health Service Report; 2004. Available from: http:\/\/www.cancerscreening.nhs.uk\/prostate\/second-survey-psa-tests.pdf [accessed 15.04.10]."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782112001099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782112001099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T10:36:50Z","timestamp":1687689410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782112001099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1877782112001099"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2012.07.012","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}